The energy-generating membrane protein NADH dehydrogenase (NDH-2), a proposed antibacterial drug target (see "Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs" Weinstein et al. 2005 [1]), was screened for modulators of activity in either detergent-solublised or lipid reconstituted (proteolipsome) form. Here we present an annotated list of compounds identified in a small-scale screen against NDH-2. The dataset contains information regarding the libraries screened, the identities of hit compounds and the physicochemical properties governing solubility and permeability. The implications of these data for future antibiotic discovery are discussed in our associated report, "Comparison of lipid and detergent enzyme environments for identifying inhibitors of membrane-bound energy-transducing proteins" [2] .
More specific subject area
Antibiotic discovery, drug discovery, microbiology The respiratory Type II NADH dehydrogenase (NDH-2) is an antimicrobial drug target and these annotated drug screening data provide information that may be used for further antimicrobial drug development.
Type of data
These data provide the identity of compounds from three libraries that either inhibit or stimulate NDH-2 activity in both detergent-solubilsed and lipid-reconstituted forms.
The list of compounds is further annotated with 'Rule of Five' properties that may be used to inform future antimicrobial drug discovery and development.
Data
These data are the annotated hits identified by screening both detergent-solubilised (DS) and lipid-reconstituted (LR) respiratory Type II NADH dehydrogenase. The table contains the library; compound name, number of H-bond donors/acceptors, molecular weight, lipophilicity (logP) and degree of inhibition/stimulation for DS and LR protein (Table 1) .
Experimental design, materials and methods
Type II NADH dehydrogenase (NDH-2) was purified and reconstituted into proteoliposomes as described by Dunn et al. [2, 3] . Detergent-solubilised (DS) NDH-2 or lipid-reconstituted (LR) NDH-2 were screened by end point 96-well assay (340 nm, Varioskan s Flash Thermo Scientific, in the presence of 100 μM menadione and 20 μM test compound. The reaction was initiated using 200 μM NADH. Screening was carried out in technical triplicate against each compound library. NADH: menadione oxidoreductase inhibition/stimulation was calculated as a percentage of control activity for either DS or LR protein [2] . Compounds showing inhibition ( r70% control) or activation ( Z130% control) in at least 2 of the 3 independent screening replicates were considered hits. Compound libraries screened were Library of Pharmacologically Active Compounds (LOPAC, SigmaAldrich), the Natural Products Set II (National Institutes of Health, USA) and the Quinolinequinone Library (Malaghan Institute of Medical Research, NZ) [4] . Hits were annotated with library of origin, chemical name and the drug-like properties governing in vivo absorption as described by the 'Rule of Five' namely, lipophilicity (logP), molecular weight, hydrogen bond donor and hydrogen bond acceptors [5] . Where necessary logP was predicted using ALOGPS software provided by the Virtual Computational Chemistry Laboratory [6] .
Acknowledgements
None. 
